Vahh Chemicals Limited is set to launch its Initial Public Offering (IPO).
It is an ISO-certified manufacturer and trader specializing in textile auxiliary chemicals with a recent foray into nutraceuticals.
Track all the IPOs of 2026 in our current IPOs section which is updated regularly.
The public issue will open for subscription on Thursday, June 4, 2026, and close on Monday, June 8, 2026.
Through this fixed-price fresh issue, the company intends to raise approximately ₹13.45 Crores at a price of ₹60 per share, primarily to fund working capital requirements and establish a new manufacturing unit in Surat.
In this article, you will find Vahh Chemicals IPO GMP today, price band, and a detailed review with strengths and risks and financial performance.
Briefs of Vahh Chemicals IPO Details:
- Issue Price: ₹60 per share (Fixed Price)
- Face Value: ₹10 per share
- IPO Open / Close Dates: June 4, 2026 – June 8, 2026
- Lot Size: Each individual lot contains 2,000 shares, but the entry-level retail application mandates buying at least 2 lots (4,000 shares).
- Issue Size: 22,42,000 Equity Shares / ~₹13.45 Crores
- Fresh Issue: 100% Fresh Issue
- Registrar: Kfin Technologies Ltd.
- Listing Exchange: BSE SME
IPO Reservation:
The offering comprises a total issue size of 22,42,000 shares.
After reserving 1,14,000 shares for the Market Maker, the net offer to the public is 21,28,000 shares, allocated as follows:
- NII & QIB Portion (Non-Individual): 10,64,000 Equity Shares (50.00% of the Net Issue). (Note: As a fixed-price issue, there is no separate Anchor Offer or specific QIB carve-out; institutional and HNI investors bid in this combined pool).
- Retail (RII) Portion: 10,64,000 Equity Shares (50.00% of the Net Issue).
What is the Vahh Chemicals IPO GMP Today?
Visit our centralized grey market premium dashboard to view daily market trends for this IPO, though you must remember that these unregulated metrics are driven purely by sentiment, lack SEBI validation, and should not be used your final investment strategy.
When are the Key Event Dates for the Vahh Chemicals IPO Allotment and Market Listing
For investors planning their capital allocation, here is the critical timeline for the issue:
- IPO Open Date: Thursday, June 4, 2026
- IPO Close Date: Monday, June 8, 2026
- Basis of Allotment Date: Tuesday, June 9, 2026
- Refund Initiation Date: Wednesday, June 10, 2026
- Credit of Shares: Wednesday, June 10, 2026
- Listing Date: Thursday, June 11, 2026
What Are The Objectives of Vahh Chemicals IPO?
The company proposes to utilize the Net Proceeds from the Fresh Issue towards the following strategic purposes:
- Working Capital: A significant portion of ₹5.84 Crores is earmarked for meeting incremental working capital requirements. This is crucial given the high debtor turnover days inherent in the B2B chemical sector.
- Capital Expenditure: ₹1.84 Crores will be deployed to set up a new manufacturing facility in Surat for backward integration, reducing reliance on third-party suppliers for core raw materials like Silicones.
- Debt Repayment: ₹1.79 Crores is allocated to repay unsecured loans previously availed from promoters, helping to lower finance costs.
- General Corporate Purposes: The remaining balance (capped at 15% of gross proceeds) will fund ongoing business exigencies.
How is The Financial Performance of Vahh Chemicals?
The provided data aggregates the corporate group's financial performance using revised statements.
(Figures in ₹ Crores)
Particulars | Period Ended 30 Sep 25 (6M) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
Total Income | 16.53 | 23.75 | 10.16 | 7.46 |
Profit After Tax (PAT) | 2.08 | 2.58 | 0.34 | 0.17 |
EBITDA | 3.39 | 4.68 | 1.12 | 0.43 |
Total Borrowing | 7.93 | 11.25 | 6.09 | 2.77 |
Assets | 42.31 | 39.28 | 7.93 | 5.12 |
Source: RHP
Financial Analysis & Observations:
Total Income:
The company demonstrated exceptional revenue growth, leaping from ₹7.46 Crores in FY23 to ₹23.75 Crores in FY25.
This aggressive scaling continued into the 6-month stub period of FY26 with ₹16.53 Crores, driven by increased client orders, a shift toward customized blending, and a highly successful entry into the nutraceutical segment.
Profit After Tax (PAT):
Profitability surged remarkably, from a mere ₹0.17 Crores in FY23 to ₹2.58 Crores in FY25.
The PAT margin expansion to over 10% in FY25 highlights the lucrative nature of its product diversification strategy.
EBITDA:
Operational efficiency improved significantly, with EBITDA expanding from ₹0.43 Crores in FY23 to ₹4.68 Crores in FY25.
The strong EBITDA margin of nearly 20% indicates the company's ability to command better pricing and manage input costs despite raw material volatility.
Total Borrowing:
To fund its explosive growth, borrowings peaked at ₹11.25 Crores in FY25 but were moderated to ₹7.93 Crores by September 2025.
The high borrowings were primarily utilized to fund the massive working capital requirements necessary to hold extended inventory and receivables.
Assets:
The asset base multiplied dramatically from ₹7.93 Crores in FY24 to ₹39.28 Crores in FY25, largely mirroring the substantial build-up in current assets (inventory and trade receivables) and the absorption of proprietary businesses owned by promoters.
What Are The P/E Ratio and Peer Comparison?
To understand the valuation, we look at the Price-to-Earnings (P/E) ratio calculated at the fixed issue price.
- Issue Price: ₹60
- EPS (FY25): ₹4.99
- P/E Ratio: ~12.02x
Peer Comparison Table (FY 2024-25 Data):
Company | P/E Ratio | RoNW (%) | EPS (₹) |
Vahh Chemicals | 12.02 | 38.52 | 4.99 |
| Bhatia Colour Chem Limited | 121.68 | 5.10 | 3.01 |
Analysis:
Vahh Chemicals is entering the market at a P/E multiple of approximately 12.02x based on its FY25 EPS. When compared to its listed peer, Bhatia Colour Chem, which trades at an exorbitant P/E of 121.68x, the issue appears to be priced at a massive discount.
More importantly, Vahh Chemicals boasts a vastly superior Return on Net Worth (RoNW) of 38.52% against its peer's 5.10%, suggesting exceptionally efficient capital utilization. This combination of a low P/E and high RoNW makes the pricing look highly attractive.
What is the Industry Outlook for Vahh Chemicals Limited?
Growth Potential:
The Indian specialty chemicals sector, particularly textile auxiliaries, is experiencing robust growth driven by the "China Plus One" sourcing strategy and strong domestic textile manufacturing demand.
Market Trends:
There is a growing shift toward integrated chemical manufacturers capable of backward integration to secure raw material supply lines. Furthermore, Vahh's diversification into the fast-growing nutraceutical market provides an additional, high-margin revenue avenue.
What Are The Strengths and Risks of Vahh Chemicals IPO?
Strengths:
- Exceptional Return Ratios: A RoNW of over 38% indicates highly aggressive and efficient use of capital.
- Strategic Diversification: The successful entry into nutraceuticals (contributing ~37% of revenue in H1 FY26) reduces reliance purely on textile chemicals.
- Valuation Comfort: At a P/E of ~12x, the pricing leaves significant room for upside when compared to its listed peer.
Risks:
- Severe Cash Flow Strain: The company operates on extended credit terms (debtor days >200), leading to consistently negative operating cash flows in recent fiscal years.
- High Client Concentration: The top 10 customers contributed 60% of revenue in FY25, posing a significant risk if key relationships are terminated.
- Supplier Dependence: The company lacks long-term supply contracts, leaving margins highly exposed to raw material price shocks.
Key Considerations for Investors
Investors should note the Minimum Investment structure.
- Minimum Application: The lot size is 2,000 Shares. Based on the data provided, the minimum application for Retail Individual Investors is 2 Lots (4,000 Shares), amounting to ₹2,40,000. Note: This investment amount exceeds the typical ₹2 Lakh retail limit, which implies this category effectively targets Small-HNI investors.
- Valuation vs. Risk: While the financial growth and valuation are compelling, the persistent negative operating cash flows and heavy working capital intensity are critical structural risks that require careful monitoring.
- Promoter Acquisition Cost: Investors should note that the promoters' average cost of acquisition is significantly lower (₹0.28 to ₹8.29) than the IPO price of ₹60.
Key Takeaways
- IPO Price: ₹60 per share (Fixed Price).
- Min Investment: ₹2,40,000 (4,000 Shares).
- Valuation: P/E of ~12.02x (Deep Discount to Peer).
- Financials: Revenue ₹23.75 Cr (FY25); Negative Cash Flows.
- Listing: BSE SME platform on June 11, 2026.
Important IPO links:
3. Daywise IPO Subscription Details
4. IPO GMP vs Listing Accuracy Study 2026
5. IPO Valuation vs Listing Performance Study 2026
6. IPO Listing Performance Tracker 2026 – Complete Dataset of IPO Listing Gains in India
FAQs on Vahh Chemicals IPO
What is Vahh Chemicals IPO GMP today?
Check at our latest gmp update page.
What is Vahh Chemicals IPO price band?
The issue is a fixed-price offering set exactly at ₹60 per equity share.
What is Vahh Chemicals IPO allotment date?
The allotment status is expected to be finalized on Tuesday, June 9, 2026.
How to check Vahh Chemicals IPO allotment status?
Investors can check the status on the website of Kfin Technologies Ltd. (the Registrar) or via the BSE IPO allotment portal.
What is Vahh Chemicals IPO listing date?
The shares are tentatively scheduled to list on Thursday, June 11, 2026.
Investment Perspective on Vahh Chemicals IPO
Vahh Chemicals offers a high-growth opportunity with attractive return ratios and a compelling valuation relative to its peer. The strategic expansion into nutraceuticals and backward integration are strong catalysts. However, the persistent negative operating cash flows and high client/supplier concentration are significant risks that prospective investors must weigh heavily.
Disclaimer:
This article is strictly for educational purposes. Please consult a SEBI-registered investment advisor before making any investment decisions.
